4//SEC Filing
Salinas Eliseo Oreste 4
Accession 0001209191-21-023476
CIK 0001787297other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 7:01 PM ET
Size
10.6 KB
Accession
0001209191-21-023476
Insider Transaction Report
Form 4
Salinas Eliseo Oreste
Chief Res. & Develop Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2021-03-22+275,000→ 275,000 totalExercise: $18.85Exp: 2031-03-22→ Common Stock (275,000 underlying) - Award
Restricted Stock Unit (RSU)
2021-03-22+60,000→ 60,000 total→ Common Stock (60,000 underlying) - Award
Restricted Stock Unit (RSU)
2021-03-22+40,000→ 40,000 total→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The option vests as to 25% of the total shares on March 22, 2022, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on March 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]The RSUs shall vest as to 33.33% of the total shares each on June 15, 2021, September 15, 2021 and December 15, 2021, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F4]1/4 of the RSUs will vest on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001435756
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 7:01 PM ET
- Size
- 10.6 KB